01-08-2008 | Original Article
Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer
Published in: International Journal of Clinical Oncology | Issue 4/2008
Login to get access01-08-2008 | Original Article
Published in: International Journal of Clinical Oncology | Issue 4/2008
Login to get access